Concord Biotech

Concord Biotech Ltd Quarterly Results

NSEBSE

₹1,839.6

(0.88%)

Jun 30, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2025	Dec-2024	Sept-2024	Jun-2024	Mar-2024
Gross Sales	429.88	244.22	310.18	215.8	318.97
Excise Duty	0	0	0	0	0
Net Sales	429.88	244.22	310.18	215.8	318.97
Other Operating Income	0	0	0	0	0
Other Income	9.38	16.56	10.03	11.66	10.81
Total Income	439.27	260.78	320.21	227.46	329.78
Total Expenditure	241.01	146.27	176.46	134.52	186.88
PBIDT	198.26	114.51	143.75	92.94	142.9
Interest	0.1	0.1	0.1	0.24	0.46
PBDT	198.16	114.42	143.65	92.7	142.44
Depreciation	14.62	13.26	13.31	13.18	13.72
Minority Interest Before NP	0	0	0	0	0
Tax	41.82	23.69	34.06	19.39	29.98
Deferred Tax	1.34	1.54	0.53	0.53	3.73
Reported Profit After Tax	140.39	75.92	95.74	59.59	95.02
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	140.39	75.92	95.74	59.59	95.02
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	140.39	75.92	95.74	59.59	95.02
EPS (Unit Curr.)	13.42	7.26	9.15	5.7	9.08
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	10.46	10.46	10.46	10.46	10.46
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	46.11	46.88	46.34	43.06	44.8
PBDTM(%)	46.09	46.85	46.31	42.95	44.65
PATM(%)	32.65	31.08	30.86	27.61	29.78